TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: energy expenditure during fast walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time during fast walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sexual function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: objective knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Executive Function (EF) behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: myocardial glucose metabolic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hb level at POD3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hct level of drainage at 24h after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Complications (nausea and vomiting)
Endpoint domain: Adverse events/effects
Primary endpoint: Adherence and satisfaction with the eHealth program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Restricted cervical range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety, depression, and insomnia prevalence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Respiratory reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean QALY difference
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: improved access to substance misuse services
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Acceptance of digital interventions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum force applied on the maxillary incisors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum force applied on the tongue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: nonwork activity impairment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Frequency of smoking discussions
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: BCRL risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean daily NRS pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesic dose requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first analgesic dose requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean changes in monthly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in the grade of HE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower time to recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower 28-day mortality
Endpoint domain: Mortality/survival
Primary endpoint: Size of ischemic ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: immediate postoperative tourniquet site pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acetaminophen consumption during the first 48 hours after surgery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in fecal microbial composition (βdiversity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased proportions of Bifidobacterium spp.
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modulation of fecal and plasma metabolite profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptable pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for electroporation over standard injection
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: flexion-rotation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital Recovery Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SS-QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: incidence of missed twice‐daily brushing episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lymphocytopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Physical performance on the Six-Minute Walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical quality of life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mental quality of life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: rate of severe PPCs
Endpoint domain: Adverse events/effects
Primary endpoint: Arterial maximal flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protective drinking strategies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Study medication compliance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence of recurrence of cellulitis
Endpoint domain: Adverse events/effects
Primary endpoint: Hospitalization for cellulitis
Endpoint domain: Adverse events/effects
Primary endpoint: Needling time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Comfort Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reporting of blinding status
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: us-CRP concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Quality of life as measured with the Parkinson’s Disease Questionnaire 39
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Motor symptoms as measured with the Movement Disorders Society‐Unified Parkinson’s Disease Rating Scale—part III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: estimated resting energy expenditure for walking activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional independence in activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: self-perception of living a meaningful life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coverage rates for praziquantel and albendazole
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Peripheral airway wall thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinical cure at the TOC visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean amplitude of sensed and paced FFRW bipolar signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean amplitude of atrial bipolar signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FFRW oversensing rate
Endpoint domain: Adverse events/effects
Primary endpoint: cessation outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: further skin grafting
Endpoint domain: Adverse events/effects
Primary endpoint: contracture formation
Endpoint domain: Adverse events/effects
Primary endpoint: changes in whole-body BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protection against moderate to severe-critical Covid-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine efficacy against severe-critical Covid-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of skin lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Deposition of collagen and elastic fibers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Caspase-3 protein expression values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in DAS28-ESR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean percent ECD loss from baseline to 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients with postoperative IOP ≥30 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Eccentric elbow flexor force production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Concentric hip abduction force production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: PREDIMED score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemoglobin reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in sexual function at 1 year after surgery
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Rates of dyspareunia at 1 year after surgery
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: lipid index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: macrophage grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean total volume of exudate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of successfully administered PCEA boluses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in motor and sensory function of the more affected upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength of deep neck flexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rates (Harvey‐Bradshaw Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Response rates (decrease in Crohn's Disease Activity Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: First Major Cardiovascular Event
Endpoint domain: Mortality/survival
Primary endpoint: Total Ischemic Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Young's modulus values of placentas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain activation in response to food anticipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain activation in response to food receipt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Refractive reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central corneal flattening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healthy behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: unhealthy behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean number of complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Recovery-15 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mitochondrial H2O2 emission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mitochondrial H2O2 production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICU mortality of early IAPA
Endpoint domain: Mortality/survival
Primary endpoint: Obesity diagnosis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean time duration to resolve fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of children without fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean value of temperature reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tregs percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Positive emotions expressed by children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RBD-specific ELISA antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pseudovirus neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pressure sensitivity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Function evaluation of fingers repaired with different flaps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with finger repair
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Visual Acuity (VA) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Central Subfield Thickness (CST) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %BMIp95
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incident stroke
Endpoint domain: Mortality/survival
Primary endpoint: Bazaz scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Osteotomy depth deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Osteotomy direction deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of sleep problems
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Quality of life for people with dementia
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incident hypokalemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Long-term physical activity (LTPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graft success rate at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of permanent pacemaker implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Consumption of sugar-sweetened beverages (SSB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADAS-Cog-Plus performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dermatology Life Quality Index (DLQI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to receive influenza vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-intervention KAP scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: PTX-3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of serum GH and IGF-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Scores of TCM symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Receiving the COVID-19 vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft-tissue Pog thickness change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OPTION-5 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Top collaboRATE score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concordance of EOL treatment preferences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence/progression of GR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Telemetry days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive mood effects
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sedative effects
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's obesity-related behaviours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parents' emotional and social wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduced sexual aggression intentions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: amount of pain-free time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morphine rescue requests
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Discrimination of CA prediction nomogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calibration of CA prediction nomogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative bioavailability of slow-release minitablets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of comorbidity symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appetite stimulant activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of postoperative wound draining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of puncture interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Volume of fluid collections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge of facilitative strategies
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: positive attitudes towards aphasia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adrenal crisis occurrence
Endpoint domain: Mortality/survival
Primary endpoint: 24-hour urinary excretion of cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: travel time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of AN (Anorexia Nervosa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of anxiety disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS-QoL score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EQ-5D-5L utility score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to return to baseline after heel puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NHS of migraine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NCO rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in urticaria symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Somnolence levels
Endpoint domain: Adverse events/effects
Primary endpoint: Mean difference in changes of LS BMD Z‐score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in NfL in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in NSE in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in S100b in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Genetic counseling uptake at 6 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Genetic testing uptake at 24 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Perceived breast cancer risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diastolic nighttime ambulatory blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma levels of angiotensin II, aldosterone, and cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: percent weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: proportion of patients with at least 10% weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of items correctly filled in
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TVAL% reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: CR-TLF reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Risk of inguinal hernia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes